DOD Biotech PCL (BKK:DOD)
Thailand · Delayed Price · Currency is THB 1.530
+0.010 (0.66%)
Feb 6, 2026, 9:58 AM ICT
DOD Biotech PCL Cash Flow Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 50.99 | -159.33 | 7.19 | -398.33 | 49.79 | 141.25 |
Depreciation & Amortization | 41.19 | 59.57 | 72.26 | 62.87 | 67.04 | 76.57 |
Other Amortization | 1.1 | 1.1 | 1.2 | 1.64 | - | - |
Loss (Gain) From Sale of Assets | -5.03 | 12.43 | 0.06 | 12.2 | 22.4 | 0.15 |
Asset Writedown & Restructuring Costs | -0 | 149.55 | - | - | 106.64 | 128.3 |
Loss (Gain) From Sale of Investments | 0.47 | -20.95 | -10.05 | 404.64 | -6.14 | 25.6 |
Other Operating Activities | -52.08 | 184.65 | 84.49 | -59.66 | 253.32 | 165.01 |
Change in Accounts Receivable | -8.01 | 89.58 | -43.44 | -124.57 | -66.1 | -67.33 |
Change in Inventory | 81.73 | 14.29 | -8.16 | 48.02 | 54.64 | -130.88 |
Change in Accounts Payable | -9.93 | -40.14 | -8.93 | -7.65 | -116.82 | 121.73 |
Change in Unearned Revenue | -1.17 | -7.4 | 11.73 | - | - | - |
Change in Other Net Operating Assets | 3.62 | -23.05 | -23.8 | -8.46 | 4.12 | 19.76 |
Operating Cash Flow | 102.36 | 34.8 | 22.8 | -130.71 | 145 | 322.2 |
Operating Cash Flow Growth | 122.89% | 52.65% | - | - | -55.00% | - |
Capital Expenditures | -40.55 | -22.49 | -18.07 | -63.29 | -182.93 | -127.55 |
Sale of Property, Plant & Equipment | 0.17 | 0.11 | - | 1.42 | 2.35 | 0.18 |
Cash Acquisitions | - | - | -71.66 | - | - | - |
Divestitures | 0 | 4.79 | - | - | - | - |
Sale (Purchase) of Real Estate | 86 | 215 | - | - | - | - |
Investment in Securities | -131.96 | - | - | - | 109.08 | - |
Other Investing Activities | -14.65 | -0.17 | -0.06 | -0.25 | -0.86 | -0.2 |
Investing Cash Flow | -100.99 | 197.24 | -89.79 | -62.12 | -72.36 | -127.57 |
Short-Term Debt Issued | - | - | 9 | 71.7 | - | 37.24 |
Long-Term Debt Issued | - | - | - | - | 22.31 | 16.6 |
Total Debt Issued | 47 | - | 9 | 71.7 | 22.31 | 53.84 |
Short-Term Debt Repaid | - | -65.49 | -47.21 | - | -53.39 | - |
Long-Term Debt Repaid | - | -6.12 | -25.16 | -31.54 | -44.39 | -44.38 |
Total Debt Repaid | -66.57 | -71.6 | -72.36 | -31.54 | -97.78 | -44.38 |
Net Debt Issued (Repaid) | -19.57 | -71.6 | -63.36 | 40.16 | -75.47 | 9.46 |
Issuance of Common Stock | - | - | 159.4 | 0 | 20.51 | - |
Common Dividends Paid | - | - | - | - | - | -143.5 |
Other Financing Activities | -1.28 | -5.34 | 8.68 | 21.26 | 1 | - |
Financing Cash Flow | -20.85 | -76.94 | 104.72 | 61.42 | -53.96 | -134.04 |
Net Cash Flow | -19.48 | 155.1 | 37.72 | -131.41 | 18.68 | 60.58 |
Free Cash Flow | 61.81 | 12.31 | 4.72 | -194 | -37.93 | 194.64 |
Free Cash Flow Growth | 81.31% | 160.59% | - | - | - | - |
Free Cash Flow Margin | 9.77% | 1.86% | 0.68% | -35.38% | -3.72% | 18.02% |
Free Cash Flow Per Share | 0.14 | 0.03 | 0.01 | -0.47 | -0.09 | 0.47 |
Cash Interest Paid | - | 0.2 | 5.34 | 4.27 | 4.74 | 9.52 |
Cash Income Tax Paid | 4.78 | 26.4 | 4.74 | 3.35 | 43.85 | 19.17 |
Levered Free Cash Flow | 111.18 | 108.19 | 4.28 | 271.63 | -2.39 | 140.08 |
Unlevered Free Cash Flow | 112.8 | 110.52 | 7.6 | 276.07 | 1.8 | 144.37 |
Change in Working Capital | 66.24 | 33.28 | -72.6 | -92.66 | -124.15 | -56.71 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.